Home Musk’s Neuralink faces its biggest test yet with human trials

Musk’s Neuralink faces its biggest test yet with human trials

Elon Musk’s neurotechnology company Neuralink is preparing for the most high-stakes launch of the billionaire entrepreneur’s career — its first-ever human clinical trial.

According to a recent Bloomberg report, the secretive startup seeks to recruit a volunteer willing to undergo brain surgery to have a chunk of their skull removed and Neuralink’s quarter-sized computer implant inserted. Ideal candidates are paralyzed adults under 40, as Neuralink aims to demonstrate the safety and utility of the device in collecting brain signals from the motor cortex in quadriplegics.

The implant’s electrode “threads” would be inserted into the brain’s hand area, allowing patients to potentially control computer cursors and robotic limbs just by thinking about moving their paralyzed limbs.

It’s a small but crucial first step toward the company’s lofty goal of creating a brain-machine interface that enhances human capabilities. Neuralink envisions a future where thousands have “robosurgery” to become cybernetic humans who can download knowledge directly to their brain chips.

Some scientists argue that Neuralink is distorting expectations about current capabilities.

The company said human trials could start in 2020 but has faced lengthy regulations reviews. Rival devices are already in human testing but lack Neuralink’s electrode density or computing power.

With brains, even tiny mistakes could have disastrous outcomes. Neuralink has aggressively accelerated the slow-moving field, investing in custom surgical robots and manufacturing. However, experts caution brain implants cannot be rushed to market with typical Silicon Valley “move fast and break things” thinking.

Animal rights groups have accused Neuralink of botched surgeries and mistreatment of test monkeys and pigs. But employees contend the animals receive excellent care and more natural lives than in typical labs. Regulators recently cleared the company to implant more humans in 2024, suggesting satisfactory safety data.

Investor hype around brain-machine interfaces has ballooned amid Neuralink’s flashy promises. Despite its setbacks, the company has reset expectations of what neural implants could achieve. But the stakes are far higher with human trials, and mistakes could set the field back years. For Musk, the pressure to succeed is enormous.

Featured Image Credit: Google DeepMind; Pexels; Thank you!

About ReadWrite’s Editorial Process

The ReadWrite Editorial policy involves closely monitoring the tech industry for major developments, new product launches, AI breakthroughs, video game releases and other newsworthy events. Editors assign relevant stories to staff writers or freelance contributors with expertise in each particular topic area. Before publication, articles go through a rigorous round of editing for accuracy, clarity, and to ensure adherence to ReadWrite's style guidelines.

Radek Zielinski
Tech Journalist

Radek Zielinski is an experienced technology and financial journalist with a passion for cybersecurity and futurology.

Get the biggest tech headlines of the day delivered to your inbox

    By signing up, you agree to our Terms and Privacy Policy. Unsubscribe anytime.

    Tech News

    Explore the latest in tech with our Tech News. We cut through the noise for concise, relevant updates, keeping you informed about the rapidly evolving tech landscape with curated content that separates signal from noise.

    In-Depth Tech Stories

    Explore tech impact in In-Depth Stories. Narrative data journalism offers comprehensive analyses, revealing stories behind data. Understand industry trends for a deeper perspective on tech's intricate relationships with society.

    Expert Reviews

    Empower decisions with Expert Reviews, merging industry expertise and insightful analysis. Delve into tech intricacies, get the best deals, and stay ahead with our trustworthy guide to navigating the ever-changing tech market.